[Palliative chemotherapy of bronchial cancers. Current status of the problem].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use; D001984:Bronchial Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004640:Emetine / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008937:Mitomycins / Q000627:therapeutic use; D009150:Mustard Compounds / Q000627:therapeutic use; D010166:Palliative Care; D011344:Procarbazine / Q000627:therapeutic use; D013852:Thiotepa / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D008937:Mitomycins; D009150:Mustard Compounds; D003561:Cytarabine; D001761:Bleomycin; D011344:Procarbazine; D014747:Vinblastine; D004317:Doxorubicin; D003520:Cyclophosphamide; D013852:Thiotepa; D005472:Fluorouracil; D006918:Hydroxyurea; D004640:Emetine; D008727:Methotrexate
La chimiothérapie palliative des cnacers bronchiques. Etat actuel de la question